Skip to main content

Grubka Robert L.'s Form 4/A amendment

Amended

Voya Financial, Inc. (VOYA) · filed Mar 2, 2022

Accession no.
0001127602-22-007783
Filed
Mar 2, 2022
Trade date
Feb 22, 2022
Filing delay
8 days
Rule 10b5-1 plan
Not on the form (before 2023)
Original filed
Feb 24, 2022

This filing lists 1 derivative transaction. It carries over 6 transactions from the original filing that it did not restate. Open-market sales total $171.3K. It was filed 8 days after the trade.

This amendment restates part of 0001127602-22-006686 (filed Feb 24, 2022). The transactions it did not restate still count and are listed below.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Grubka Robert L.CIK 0001852036Officer (See Remarks)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

This filing has no transactions of this kind.

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Feb 22, 2022Common StockAGrant or awardAcquired+10,611$0.00$026,827Direct

Carried over from the original filing

This amendment restates only part of the original filing. The original's other transactions still stand, and the trade tables on Livermore count them under this amendment.

From 0001127602-22-006686 (filed Feb 24, 2022).

Non-derivative securities (Table I)

Non-derivative transactions carried over from 0001127602-22-006686
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 22, 2022Common StockMOption exerciseAcquired+11,698$0.00F1$028,837Direct
Feb 22, 2022Common StockFTax withholdingDisposed−5,263$68.32−$359,568.1623,574Direct
Feb 22, 2022Common StockSSaleDisposed−2,500$68.50F3−$171,25021,074Direct

Derivative securities (Table II)

Derivative transactions carried over from 0001127602-22-006686
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Feb 22, 2022Common StockMOption exerciseDisposed−5,446$0.00$016,216Direct
Feb 22, 2022Common StockMOption exerciseDisposed−6,252$0.00$07,846Direct
Feb 22, 2022Common StockAGrant or awardAcquired+8,562$0.00$016,408Direct

Footnotes on the original

The footnotes that the prices of these transactions refer to on the original filing.

F1

Delivery of shares of the company's common stock was made to the reporting person without the payment of any consideration in connection with the vesting of the underlying restricted stock units and performance stock units that were awarded as compensation.

Referenced by the price of 1 transaction in Table I.

F3

This transaction was executed in multiple trades at prices ranging from $67.76 to $69.185. The price report represents the weighted average sale price of these trades. The reporting person hereby undertakes to provide upon request to the SEC Staff, the company, or a security holder of the company, full information regarding the shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The performance stock units were awarded as compensation and convert to common stock based on the achievement of certain performance factors.

F2

The reporting person's original Form 4 filed on February 24, 2022 inadvertently understated the amount of performance stock units awarded to the reporting person on the transaction date by 634 shares.

Remarks

CEO, Health Solutions

Read the full filing on SEC EDGAR (opens in a new tab)